Dr. Patrick Donovan Lyden, MD

Dr. Lyden practices at Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California.

Dr. Lyden's NPI, 1215962113, was assigned on July 11, 2006. Dr. Lyden graduated from Baylor College Of Medicine in 1981. Dr. Lyden's California license number on file is G48156.

Dr. Lyden's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD, at 1450 San Pablo St, Los Angeles, CA 90033.

Dr. Lyden's primary practice is Keck Medicine of USC - USC Roski Eye Institute - Ophthalmology - HOPD in Los Angeles, California. Dr. Lyden is also affiliated with Cedars-Sinai Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Lyden to 1 more hospital, 1 group practice or clinic and 1 other site, each named with a free account. Dr. Lyden's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lyden practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Lyden's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Lyden is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Lyden has a license on file in California.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, epilepsy, essential tremor, fibromyalgia and chronic pain, head injury, lower back pain and migraine and chronic headache among the conditions Dr. Lyden treats.

CMS data shows 51 Medicare services from Dr. Lyden across 2 procedure codes in 2024, all of them office visits, for 47 Medicare patients. Medicare paid $4,446 for them. Every service was in an office.

CMS counts 47 Medicare patients who saw Dr. Lyden in 2024. The largest group is 75 to 84, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.76, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lyden's median patient age at 67, with 38% women.

In 2024, Dr. Lyden wrote 62 Medicare Part D claims for 17 patients. 97% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $706 in total drug cost. In 2023, CMS named 56 claims across 3 drugs.

Dr. Lyden accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lyden as offering telehealth.

Dmand AI links 30 papers to Dr. Lyden, published from 2010 to 2025. 2019 was the busiest year, with 4. The most frequent topics are Brain Ischemia and Cognition. Dr. Lyden has published most often in ArXiv. Dr. Lyden's most frequent co-authors are Oana M. Dumitrascu, MD, Shlee Sang-Hyun Song, MD and Konrad H. Schlick, MD.

Dmand AI links Dr. Lyden to 7 clinical trials, 2 of them phase 1 studies. Conditions studied include Hypothermia, Ischemic Stroke and Body Temperature Changes. University of California, San Diego sponsors the most, 2. Open Payments lists research payments to Dr. Lyden that name 2 trials.

CMS Open Payments shows 15 general payments to Dr. Lyden from 5 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 50% of the total. Genentech, Inc. paid the most, $17,913. It also lists 10 research payments totaling $5,066 from 2016 to 2024, naming 2 clinical trials.

Dmand AI lists 1 award for Dr. Lyden, most recently CMS Stage 1 EHR in 2013.

Dr. Lyden graduated from Baylor College Of Medicine in 1981.

Dr. Lyden is in network with 6 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.